Antibiotic susceptibilities of Yersinia enterocolitica recovered from children over a 12-year period

International Journal of Antimicrobial Agents
N M Abdel-HaqW J Brown

Abstract

Antibiotic susceptibility testing by the microdilution technique was performed on 184 Yersinia enterocolitica isolates recovered from children with gastroenteritis in the Detroit area during a 12-year period. The majority of isolates were resistant to ampicillin, ticarcillin and cefazolin. The most active agents were cefotaxime, ceftriaxone, cefepime, gentamicin, tobramycin, sulphamethoxazole/trimethoprim, imipenem and ciprofloxacin. Cefotaxime and ceftriaxone were effective in the treatment of bacteraemia in 12 patients.

References

Apr 1, 1975·Journal of General Microbiology·G Cornelis, E P Abraham
Jan 1, 1977·CRC Critical Reviews in Microbiology·E J Bottone
Jul 6, 1989·The New England Journal of Medicine·T L Cover, R C Aber
May 1, 1985·Antimicrobial Agents and Chemotherapy·M J HornsteinP A Grimont
Jan 1, 1988·Scandinavian Journal of Infectious Diseases·E P TralleroL Solaun
Jan 1, 1987·Drugs·J A Hoogkamp-Korstanje
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·R K ScribnerC H Pai
Jul 1, 1980·The Journal of Pediatrics·M J BlaserR A Pollard
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·M A PrestonC Krishnan
Sep 1, 1995·The Pediatric Infectious Disease Journal·J A Hoogkamp-Korstanje, V M Stolk-Engelaar
Nov 1, 1995·The Journal of Antimicrobial Chemotherapy·V M Stolk-EngelaarJ A Hoogkamp-Korstanje
Apr 8, 2000·International Journal of Antimicrobial Agents·W RastawickiJ Jeljaszewicz
Oct 31, 2000·The Pediatric Infectious Disease Journal·N M Abdel-HaqW J Brown
Dec 5, 2000·The Journal of Antimicrobial Chemotherapy·J N PhamE Carniel

❮ Previous
Next ❯

Citations

May 17, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Cornelia MeyerMaria Fredriksson-Ahomaa
Jun 29, 2007·The Pediatric Infectious Disease Journal·J Elliot Carter, John J Nelson
Oct 25, 2011·Enfermedades infecciosas y microbiología clínica·Anna Fàbrega, Jordi Vila
Aug 19, 2015·Enfermedades infecciosas y microbiología clínica·Ana González-TorralbaJuan-Ignacio Alós
Dec 7, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Iyad A El QouqaAbdel Moati Kh Al Jarousha
Jul 3, 2008·Journal of Food Protection·Irene V WesleyEric Bush

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.